Celyad: Some Questions For Management

  • I recently  covered Celyad, and I have quite a few questions about the company.
  • I have tried to answer some of them here myself.
  • The rest are addressed to management.

By Dr. Udaya K Maiya, MBBS, MD, DNB, DCCF-Paris

I recently covered Celyad (CYAD), a small Belgian company developing CAR-T therapy for solid tumors, and I have a few follow up questions. Some of these needs to be answered by management, but some I could probably answer.

The full post is available to investor members only. Subscribe here.